Vaccination Strategies and Immune Modulation of Atherosclerosis
Authors:
- 24 April 2020
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 126 (9) , 1281-1296
Abstract
Adaptive as well as innate immune responses contribute to the development of atherosclerosis. Studies performed in experimental animals have revealed that some of these immune responses are protective while others contribute to the progression of disease. These observations suggest that it may be possible to develop novel therapies for cardiovascular disease by selectively modulating such atheroprotective and proatherogenic immunity. Recent advances in cancer treatment using immune check inhibitors and CAR (chimeric antigen receptor) T-cell therapy serve as excellent examples of the possibilities of targeting the immune system to combat disease. LDL (low-density lipoprotein) that has accumulated in the artery wall is a key autoantigen in atherosclerosis, and activation of antigen-specific T helper 1–type T cells is thought to fuel plaque inflammation. Studies aiming to prove this concept by immunizing experimental animals with oxidized LDL particles unexpectedly resulted in activation of atheroprotective immunity involving regulatory T cells. This prompted several research groups to try to develop vaccines against atherosclerosis. In this review, we will discuss the experimental and clinical data supporting the possibility of developing immune-based therapies for lowering cardiovascular risk. We will also summarize ongoing clinical studies and discuss the challenges associated with developing an effective and safe atherosclerosis vaccine.Keywords
This publication has 117 references indexed in Scilit:
- Targeting oxidized LDL improves insulin sensitivity and immune cell function in obese Rhesus macaquesMolecular Metabolism, 2013
- T-Helper 2 Immunity Is Associated With Reduced Risk of Myocardial Infarction and StrokeArteriosclerosis, Thrombosis, and Vascular Biology, 2013
- Depletion of FOXP3+ regulatory T cells promotes hypercholesterolemia and atherosclerosisJournal of Clinical Investigation, 2013
- Influenza Infection and Risk of Acute Myocardial Infarction in England and Wales: A CALIBER Self-Controlled Case Series StudyThe Journal of Infectious Diseases, 2012
- Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studiesAnnals of the Rheumatic Diseases, 2012
- Inhibition of T cell response to native low-density lipoprotein reduces atherosclerosisJournal of Experimental Medicine, 2010
- Associations between autoantibodies against apolipoprotein B-100 peptides and vascular complications in patients with type 2 diabetesDiabetologia, 2009
- Passive immunization with monoclonal IgM antibodies against phosphorylcholine reduces accelerated vein graft atherosclerosis in apolipoprotein E-null miceAtherosclerosis, 2006
- Immunization using an Apo B-100 related epitope reduces atherosclerosis and plaque inflammation in hypercholesterolemic apo E (−/−) miceBiochemical and Biophysical Research Communications, 2005
- Mucosal Administration of Heat Shock Protein-65 Decreases Atherosclerosis and Inflammation in Aortic Arch of Low-Density Lipoprotein Receptor-Deficient MiceCirculation, 2002